Match Document Document Title Score
8569542 Use of docosatrienes, resolvins, and their stable analogs in the treatment of airway diseases and asthma  
The present invention is generally drawn to novel isolated therapeutic agents, termed resolvins, generated from the interaction between a dietary omega-3 polyunsaturated fatty acid (PUFA) such as...
71
9149424 Compositions and methods for reducing hepatotoxicity associated with drug administration  
The present invention relates to the discovery that acetylsalicylic acid (ASA or aspirin), salicylic acid (SA) and related salicylate esters and their pharmaceutically acceptable salts, when...
71
4098430 Plastic container  
An integrally formed, one-piece, generally rectangular, plastic container particularly adapted for holding medicines is disclosed. The container includes a generally rectangular bottom section...
71
US20150202193 METHOD FOR TREATING A PATIENT AT RISK FOR DEVELOPING AN NSAID-ASSOCIATED ULCER  
The present disclosure is directed to a method for treating a disease or disorder in a patient at risk of developing an NSAID-associated ulcer by administering to said patient in need thereof a...
71
7872152 Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma  
The present invention is generally drawn to novel isolated therapeutic agents, termed resolving, generated from the interaction between a dietary omega-3 polyunsaturated fatty acid (PUFA) such as...
71
8933270 Use of docasatrienes, resolvins, and their stable analogs in the treatment of airway diseases and asthma  
The present invention is generally drawn to novel isolated therapeutic agents, termed resolvins, generated from the interaction between a dietary omega-3 polyunsaturated fatty acid (PUFA) such as...
71
4215143 Anti-ulcer pharmaceutical composition containing inositol hexasulfate aluminum or sodium aluminum salt as active ingredient  
Inositol hexasulfate aluminum and sodium aluminum salts have excellent anti-ulcer, antacid and antipeptic effects. Examination of the action of these compounds on various types of experimental...
70
US20190091192 CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER  
The present invention relates to controlled release pharmaceutical compositions comprising fumaric acid ester(s) as active substance(s). The compositions are suitable for use in the treatment of...
70
3749230 CHILD-PROOF PILL BOX  
A child-proof container for aspirin tablets and the like comprises a flanged body of resilient plastic and a sheet metal cover hinged thereon and having a hook positively interlocking with a ledge...
70
US20130186779 BLISTER PACK FOR A CONTAINER  
The present invention relates to a blister pack sealed to the neck of a container and adapted to fit under the container lid forming a seal, said blister pack containing a liquid soluble material...
70
US20070254897 Compositions and methods for the treatment of cardiovascular disease  
The invention relates to methods of treating cardiovascular disease comprising administering a resolvin, lipoxin, or oxylipin compound.
70
4308280 Treatment of shock  
Pharmaceutical compositions for use in the relief of acute pulmonary edema, different types of shock including anaphylactic shock, shock induced by bacterial endotoxins, and hyperfibrinolysis...
70
US20080214646 Novel Nsaids Possessing a Nitric Oxide Donor Diazen-1-Ium-1,2-Diolate Moiety  
This invention provides a prodrug that help arthritis patients without increasing cardiovascular and gastrointestinal risk. A novel group of hybrid nitric oxide-releasing non-steroidal...
70
US20160081917 STEM CELL COMPOSITION FOR VENOUS ADMINISTRATION  
The present invention relates to a stem cell composition for intravenous administration, which contains stem cells at a concentration of 1×107 to 5×108 cells/ml, in which the stem cells have a...
70
US20180228731 POLYPHENOLIC POLYMER TO MAKE WATER-INSOLUBLE MOLECULES BECOME WATER-SOLUBLE  
The subject invention relates to compositions of a polyphenolic Polymer and methods useful for the delivery of substantially water-insoluble drugs and agrochemicals, like Artemisinin, Aspirin, and...
69
9108922 Benzamides and related inhibitors of factor Xa  
Novel benzamide compounds including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa are described....
69
US20140377247 BENZAMIDES AND RELATED INHIBITORS OF FACTOR XA  
Novel benzamide compounds including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa are described....
69
7439077 Coumarin analog compounds for safer anticoagulant treatment  
The present invention relates to the albumin-guided development of coumarin analogs and the analogs developed thereby. The coumarin analogs of the present invention are identified and isolated by...
69
7179838 Coumarin analog compounds for safer anticoagulant treatment  
The present invention relates to the albumin-guided development of coumarin analogs and the analogs developed thereby. The coumarin analogs of the present invention are identified and isolated by...
69
US20040058985 Coumarin analog compounds for safer anticoagulant treatment  
The present invention relates to the albumin-guided development of coumarin analogs and the analogs developed thereby. The coumarin analogs of the present invention are identified and isolated by...
69
US20070155828 Coumarin analog compounds for safer anticoagulant treatment  
The present invention relates to the albumin-guided development of coumarin analogs and the analogs developed thereby. The coumarin analogs of the present invention are identified and isolated by...
69
7759395 Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma  
The present invention is generally drawn to novel isolated therapeutic agents, termed resolvins, generated from the interaction between a dietary omega-3 polyunsaturated fatty acid (PUFA) such as...
69
5037815 Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 - and H2 -receptor blockers  
A pharmaceutical composition and process for administering non-steroidal drugs which are protected againsts injury to the gastrointestinal tract by a combination of certain H1 - and H2 -receptor...
69
5487899 Wound healing  
The present invention describes a composition derived from the Aloe plant which when used as an adjuvant for the healing of wounds exhibits increased anti-inflammatory and wound healing activity....
69
US20050202085 Unit dose of material in system and method  
The invention provides a unit dose of an orally consumable material, having a predetermined pharmaceutically effective amount of at least one nonprescription discomfort reliever and a...
68
US20060217351 Method for treating cardiovascular diseases  
A method of treating Cardiovascular Diseases comprising administering of a compound of formula (I) or a pharmaceutically acceptable salt, solvate, prodrug, active metabolite, racemate or...
68
5066496 Composition and method for treatment of gastric and duodenal ulcers and mucosal erosions  
Ganglioside mixtures and/or lipid mixtures e.g. from brain and omentum, are found to be effective to treat peptic ulcers.
68
US20080317886 Compositions for Preventing and Reducing Delayed Onset Muscle Soreness  
The present invention relates to the compositions that enhance post-exercise recovery processes to increase both strength and muscle mass, replace glycogen stores, and prevent inflammation,...
68
10183044 Systems and methods for thrombosis prevention  
The disclosure provides a composition for inhibiting thrombosis. The composition includes 5 to 25% by weight of Fish Oil, 15 to 55% by weight of Willow Bark Extract, and 0.2 to 5% by weight of...
67
US20180325850 VALPROIC ACID FOR TREATMENT OF MYOCARDIAL ISCHEMIA  
Provided herein are pharmaceutical compositions comprising valproic acid and methods of use thereof for the treatment and/or prevention of myocardial ischemia and/or infarction.
67
US20130078305 Pharmaceutical Compositions For The Coordinated Delivery Of NSAIDs  
The present invention is directed to drug dosage forms that release an agent that raises the pH of a patient's gastrointestinal tract, followed by a non-steroidal anti-inflammatory drug. The...
67
US20120064156 Pharmaceutical Compositions for the Coordinated Delivery of NSAIDs  
The present invention is directed to drug dosage forms that release an agent that raises the pH of a patient's gastrointestinal tract, followed by a non-steroidal anti-inflammatory drug. The...
67
US20050249811 Pharmaceutical compositions for the coordinated delivery of NSAIDs  
The present invention is directed to drug dosage forms that release an agent that raises the pH of a patient's gastrointestinal tract, followed by a non-steroidal anti-inflammatory drug. The...
67
US20160089337 PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDS  
The present invention is directed to drug dosage forms that release an agent that raises the pH of a patient's gastrointestinal tract, followed by a non-steroidal anti-inflammatory drug. The...
66
US20080161274 Compounds and methods for inhibition of bone loss  
The invention relates to methods of treating or preventing bone loss, as in osteoporosis, metastatic bone disease, or periodontitis, comprising administering a compound of formula A, a compound of...
66
US20100009939 CONCURRENT DRUGS  
The present invention provides a combination drug which is useful for the prevention or treatment of thromboembolism. A pharmaceutical agent comprising an antiplatelet agent in combination with a...
65
US20190030008 CONTROLLED DOSING OF CLOPIDOGREL WITH GASTRIC ACID INHIBITION THERAPIES  
The present invention provides for novel formulations of clopidogrel in combination ton pump inhibitors (PPI), optionally with NSAIDs, for use as improved antiplatelet therapies in stroke and...
65
4849417 Acetylsalicylic acid derivative and pharmaceutical composition thereof  
The hydrated complex of magnesium acetylsalicylate and urea of formula ##STR1## possesses exceptional analgesic and antipyretic properties. It may be crystallized from a solution obtained by...
65
US20080152768 Disposable cup containing dry beverage food or medicament ingredients in liquid permeable bag heat welded to its inner surface  
A new and convenient article of commerce is comprised of a disposable cup having permanently vacuum heat-welded to the bottom thereof a small bag fashioned from woven, non-woven, or knitted...
65
US20170210971 LOW PH CROSSLINKING OF POLYMERS  
The invention is directed to polymers that self-crosslink at acidic pH or can be crosslinked by phenolic agents in brine. Such polymers have lower viscosity and can be pumped deep into reservoirs,...
65
US20040115735 Method for predicting cardiovascular events  
A novel method for assessing the risk of a cardiovascular event is provided. The concentration of 11-dehydro thromboxane in a urine sample is measured and compared to a set of standardized...
64
5036046 Method for enhancing healing of corneal endothelial wounds  
Method using a non-steroidal antiinflammatory compound, such as indomethacin and/or a growth factor that causes a change in cell function when bound to a specific cell surface receptor, such as...
64
8551958 Galactosylated pro-drugs of non-steroidal anti-inflammatories with improved pharmacokinetic characteristics and reduced toxicity of the starting drug  
Pro-drugs of all non-steroidal anti-inflammatories with free acid function derivatized with an ester group, which have the general structural formula given below (I) where A is: aspirin,...
64
9018193 Aqueous drug delivery system  
Novel water stable pharmaceutical compositions, their liquid form oral pharmaceutical compositions and kits thereof, rehydration beverages containing these water stable pharmaceutical compositions...
64
US20030111467 Auxiliary container for physical association with conventional medication container  
An auxiliary container (10) adapted for unintrusive coupling with a conventional medication container (12), such as pill bottle, cream tube, or spray can, wherein the auxiliary container (10)...
63
US20060142254 Antipyretic preparation containing xylitol  
The invention relates to an antipyretic preparation intended to be administered by any means other than orally, characterized in that it comprises xylitol, and more particularly to an antipyretic...
63
8513281 Method of treating traumatic brain and spinal cord injuries and other neurogenic conditions using non-steroidal anti-inflammatory drugs and naturally occurring conotoxins  
A method for treating a patient/subject having neuronal injury, pain, neurotrauma and/or traumatic brain injury, such as diffuse axonal injury, which includes intrathecally and/or...
62
6475530 Methods and compositions for producing weight loss  
Dislcosed are methods and compositions for producing weight loss in a mammal by administration of a composition containing a weight loss effective amount of a noradrenaline stimulating compound...
62
US20090286760 Novel Compositions and Methods for Treating Hyperproliferative Diseases  
The invention relates to a composition that includes a first agent selected including an agent that possesses anti-inflammatory activity or acetaminophen, phenacetin, tramadol and the like; a...
62
US20150359808 COMPOSITIONS AND METHODS FOR REDUCING HEPATOTOXICITY ASSOCIATED WITH DRUG ADMINISTRATION  
The present invention relates to the discovery that acetylsalicylic acid (ASA or aspirin), salicylic acid (SA) and related salicylate esters and their pharmaceutically acceptable salts, when...
62


Search
« search again